Viewing nowCombinationLotodipine Tablets 5/5 mg (Rosuvastatin, Amlodipine)
Rosuvastatin Calcium 5.2mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.

MFDS item code 202500591 · Approved 2025.03.18 · Insurance code 648105190
Treatment of hyperlipidemia and hypertension and angina; inhibition of atherosclerosis progression and cardiovascular risk
This medication is used for patients who require combination therapy with amlodipine and rosuvastatin. Amlodipine is effective in treating myocardial ischemia due to hypertension and stable or variant angina, reducing the risk of angina and vascular interventions in patients with coronary artery disease. Rosuvastatin is primarily used to control blood cholesterol levels in patients with primary and familial hypercholesterolemia, as well as combined hyperlipidemia, where dietary and exercise therapies are insufficient. It also plays a role in reducing the risk of stroke, myocardial infarction, and vascular recanalization in high-risk cardiovascular patients. The combination of these two medications improves both the prevention and treatment effects of cardiovascular diseases.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, amlodipine and rosuvastatin. ○ Amlodipine Adults: Administer 5mg of amlodipine orally once daily. The dose may be increased to a maximum of 10 mg once daily according to the patient's response. Adjust the dose as appropriate according to symptoms. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and should continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 milligrams once daily. 2. Older adults: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of rosuvastatin is contraindicated in some of these patients. Patients taking amlodipine and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This medication should not be used in patients who are allergic to certain ingredients or have shown hypersensitivity reactions. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication unless the likelihood of pregnancy is low and there is a full awareness of the risks to the fetus. Patients with severely impaired liver function or active liver disease, severe aortic stenosis, those in shock, muscle disorders, and those taking certain immunosuppressants should also avoid this medication. Patients with severe renal impairment should not use this drugs, and those at high risk for muscle disorders should be especially cautious. Patients with hypertension or renal failure, elderly patients, and those with myasthenia gravis should be closely monitored when using this medication, and regular liver function tests and muscle-related tests are recommended. If symptoms such as myalgia, muscle weakness, or cramps occur, patients should inform their healthcare provider immediately, and discontinuation of the medication may be necessary. This medication may affect the liver or kidneys, so regular testing is required, and rare but serious liver damage or severe muscle-related side effects may occur. Additionally, interactions may arise when used with other medications, so current medications must be disclosed to the doctor or pharmacist. Pregnant or nursing women should not take this medication and women capable of becoming pregnant should use appropriate contraception. Safety in children is not established, hence it is not administered to pediatric patients. In cases of overdose, severe hypotension or cardiac symptoms may occur, necessitating immediate emergency treatment, and this medication should be kept out of reach of children.
Peripheral edema, chest pain, wrist fracture, gout, dizziness, headache, flushing, fatigue, swelling, palpitations, vertigo, drowsiness, abdominal pain, nausea, weakness, lethargy, pain, weight gain, weight loss, hypotension, vasculitis, tension increase, sensory loss, sensory abnormalities, peripheral neuropathy, syncope, taste abnormalities, tremors, extrapyramidal disorder, erectile dysfunction, gynecomastia, changes in bowel habits, dry mouth, indigestion, gastritis, gingival hyperplasia, pancreatitis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, insomnia, mood changes, cough, dyspnea, rhinitis, hair loss, hyperhidrosis, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, tinnitus, visual disturbances, increased urinary frequency, urinary dysfunction, nocturia, hepatitis, jaundice, elevated liver enzymes, pruritus, rash, angioedema, erythema multiforme, myocardial infarction, arrhythmia, chest pain, hypotension, sinoatrial block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, constipation, skin erythema, maculopapular rash, heaviness, warmth sensation, impaired glucose tolerance, weakness, angioedema, hypersensitivity reaction, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, muscular disorders, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia with systemic symptom drug reaction syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, severe myasthenia gravis, ocular myasthenia, increased ALT, increased CK, increased AST, numbness, sensory abnormalities, chest discomfort, appetite loss, abdominal distension, syncope, generalized pain, muscle cramps, erectile dysfunction, acute renal failure, oliguria, increased serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air and moisture. Additionally, it is best to keep the medication at room temperature, not exceeding 30°C or falling below 1°C.
Orange round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 5.2mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Amlodipine Besylate 13.889mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationRosuvastatin Calcium 10.4mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationRosuvastatin Calcium 20.8mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationRosuvastatin Calcium 5.2mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Yuhan Corporation
Rosuvastatin Calcium 5.2mg · Amlodipine Besylate 13.889mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationRosuvastatin Calcium 10.4mg · Amlodipine Besylate 13.889mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationRosuvastatin Calcium 20.8mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.